The Stat3/GR Interaction Code: Predictive Value of Direct/Indirect DNA Recruitment for Transcription Outcome

Molecular Cell

Volumn 47, Issue 1, 2012, Pages 38-49

  Langlais, David ^a,b   Couture, Catherine ^a   Balsalobre, Aurélio ^a   Drouin, Jacques ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN; CORRELATION ANALYSIS; DNA DETERMINATION; GENOME; HORMONE RESPONSE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN TETHERING;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LIBRARY; MICE; MUTATION; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; RNA INTERFERENCE; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84863843763     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.04.021     Document Type: Article

References (43)

1. Aittomaki S., Pesu M., Groner B., Janne O.A., Palvimo J.J., Silvennoinen O. Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J. Immunol. 2000, 164:5689-5697.
2. Baschant U., Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 2010, 120:69-75.
3. Biddie S.C., John S., Sabo P.J., Thurman R.E., Johnson T.A., Schiltz R.L., Miranda T.B., Sung M.H., Trump S., Lightman S.L., et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 2011, 43:145-155.
4. Bilodeau S., Vallette-Kasic S., Gauthier Y., Figarella-Branger D., Brue T., Berthelet F., Lacroix A., Batista D., Stratakis S., Hanson J., et al. Role of Brg1 and HDAC2 in GR trans-repression of pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 2006, 20:2871-2886.
5. Bulger M.l., Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011, 144:327-339.
6. Chen T., Wang L.H., Farrar W.L. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res. 2000, 60:2132-2135.
7. Engblom D., Kornfeld J.W., Schwake L., Tronche F., Reimann A., Beug H., Hennighausen L., Moriggl R., Schutz G. Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev. 2007, 21:1157-1162.
8. Giresi P.G., Lieb J.D. Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods 2009, 48:233-239.
9. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 2010, 10:365-376.
10. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
11. Horvath C.M., Wen Z., Darnell J.E. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 1995, 9:984-994.
12. John S., Sabo P.J., Thurman R.E., Sung M.H., Biddie S.C., Johnson T.A., Hager G.L., Stamatoyannopoulos J.A. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 2011, 43:264-268.
13. Jonat C., Rahmsdorf H.J., Park K.-K., Cato A.C.B., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 1990, 62:1189-1204.
14. Kadonaga J.T. Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors. Cell 2004, 116:247-257.
15. Kagey M.H., Newman J.J., Bilodeau S., Zhan Y., Orlando D.A., van Berkum N.L., Ebmeier C.C., Goossens J., Rahl P.B., Levine S.S., Taatjes D.J., Dekker J., Young R.A. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010, 467:430-435.
16. Lamolet B., Pulichino A.M., Lamonerie T., Gauthier Y., Brue T., Enjalbert A., Drouin J. A pituitary cell-restricted T-box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 2001, 104:849-859.
17. Langlais D., Couture C., Balsalobre A., Drouin J. Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response. PLoS Genet. 2008, 4:e1000224. 10.1371/journal.pgen.1000224.
18. Langlais D., Couture C., Sylvain-Drolet G., Drouin J. A pituitary-specific enhancer of the POMC Gene with preferential activity in corticotrope cells. Mol. Endocrinol. 2011, 25:348-359.
19. Lee T.I., Young R.A. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 2000, 34:77-137.
20. Lerner L., Henriksen M.A., Zhang X., Darnell J.E. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 2003, 17:2564-2577.
21. Loeffler S., Fayard B., Weis J., Weissenberger J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int. J. Cancer 2005, 115:202-213.
22. Maira M.H., Martens C., Batsche E., Gauthier Y., Drouin J. Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol. Cell. Biol. 2003, 23:763-776.
23. Nakashima K., Yanagisawa M., Arakawa H., Kimura N., Hisatsune T., Kawabata M., Miyazono K., Taga T. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 1999, 284:479-482.
24. Niehof M., Streetz K., Rakemann T., Bischoff S.C., Manns M.P., Horn F., Trautwein C. Interleukin-6-induced tethering of STAT3 to the LAP/C/EBP+| promoter suggests a new mechanism of transcriptional regulation by STAT3. J. Biol. Chem. 2001, 276:9016-9027.
25. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 2011, 286:3177-3184.
26. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005, 122:707-721.
27. Philips A., Maira M.H., Mullick A., Chamberland M., Lesage S., Hugo P., Drouin J. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol. 1997, 17:5952-5959.
28. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 1994, 91:752-756.
29. Reddy T.E., Pauli F., Sprouse R.O., Neff N.F., Newberry K.M., Garabedian M.J., Myers R.M. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 2009, 19:2163-2171.
30. Rogatsky I., Ivashkiv L.B. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 2006, 68:1-12.
31. Schindler C., Levy D.E., Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 2007, 282:20059-20063.
32. Schule R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., Verma I.M., Evans R.M. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990, 62:1217-1226.
33. Song L., Zhang Z., Grasfeder L.L., Boyle A.P., Giresi P.G., Lee B.K., Sheffield N.C., Graf S., Huss M., Keefe D., et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011, 21:1757-1767.
34. Stocklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996, 383:726-728.
35. Stoecklin E., Wissler M., Moriggl R., Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol. Cell. Biol. 1997, 17:6708-6716.
36. Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., Li M., Chambon P. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.
37. Takeda T., Kurachi H., Yamamoto T., Nishio Y., Nakatsuji Y., Morishige K., Miyake A., Murata Y. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J. Endocrinol. 1998, 159:323-330.
38. Vegiopoulos A., Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol. Cell. Endocrinol. 2007, 275:43-61.
39. Wyszomierski S.L., Rosen J.M. Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol. Endocrinol. 2001, 15:228-240.
40. Yang-Yen H.F., Chambard J.C., Sun Y.L., Smeal T., Schmidt T.J., Drouin J., Karin M. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990, 62:1205-1215.
41. Yu H., Jove R. The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 2004, 4:97-105.
42. Zhang Z., Jones S., Hagood J.S., Fuentes N.L., Fuller G.M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 1997, 272:30607-30610.
43. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137. 10.1186/gb-2008-9-9-r137.